Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
333 participants
INTERVENTIONAL
2017-01-02
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Evaluation and Education for Alzheimer's Disease
NCT00571025
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
NCT04606420
Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability
NCT01041989
Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
NCT05599425
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
NCT07146412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tervas
Follow up group from an earlier study. Information on risk gene status. All test persons were given information on healthy diet and life style.
information on the risk gene status
information on risk gene status (APOE4 allele or not) was given before intervention
life style advise
all test persons were given information on healthy diet and life style
Informed
Information on risk gene status was given before intervention. All test persons were given information on healthy diet and life style.
information on the risk gene status
information on risk gene status (APOE4 allele or not) was given before intervention
life style advise
all test persons were given information on healthy diet and life style
non informed
Information on risk gene status was not given before intervention. All test persons were given information on healthy diet and life style.
life style advise
all test persons were given information on healthy diet and life style
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
information on the risk gene status
information on risk gene status (APOE4 allele or not) was given before intervention
life style advise
all test persons were given information on healthy diet and life style
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* overall good health (no chronic conditions e.g. mental disorders, cancer, liver or kidney disease, current or previous diagnosis),
* body mass index (BMI) under 35 kg/m2,
* blood pressure under 140/90 mmHg (medication allowed),
* serum total cholesterol under 7.25 mmol/l (medication allowed)
* fasting plasma glucose level under 7 mmol/l.
Exclusion Criteria
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turku
OTHER
University of Eastern Finland
OTHER
Academy of Finland
OTHER
Natural Resources Institute Finland
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raija Tahvonen, Prof
Role: STUDY_DIRECTOR
Natural Resources Institute Finland
References
Explore related publications, articles, or registry entries linked to this study.
Leskinen HM, Tringham M, Karjalainen H, Iso-Touru TK, Hietaranta-Luoma HL, Marnila PJ, Pihlava JM, Hurme T, Kankaanpaa SJ, Puolijoki H, Akerman K, Tanner L, Sandell M, Vahakangas K, Hopia A, Tahvonen R, Rokka LS. APOE Genotype Disclosure and Lifestyle Advice in a Randomized Intervention Study with Finnish Participants. J Nutr. 2021 Jan 4;151(1):85-97. doi: 10.1093/jn/nxaa316.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
41007-00040400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.